Literature DB >> 16179902

Venous thrombotic events in cancer: the bottom line.

John Horton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16179902     DOI： 10.1177/1073274805012003S06

Source DB:  PubMed          Journal:  Cancer Control        ISSN： 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  4 in total

1.  Hypercoagulable State.

Authors:  Cengiz Beyan
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.

Authors:  Uma H Athale; Caroline Laverdiere; Trishana Nayiager; Yves-Line Delva; Gary Foster; Lehana Thabane; Anthony Kc Chan
Journal:  BMC Cancer       Date:  2017-05-04       Impact factor: 4.430

3.  Tinzaparin inhibits VL30 retrotransposition induced by oxidative stress and/or VEGF in HC11 mouse progenitor mammary cells: Association between inhibition of cancer stem cell proliferation and mammosphere disaggregation.

Authors:  Stefania Mantziou; Georgios Markopoulos; Soteroula Thrasyvoulou; Dimitrios Noutsopoulos; Foteini Gkartziou; Georgios Vartholomatos; Theodore Tzavaras
Journal:  Oncol Rep       Date:  2021-09-24       Impact factor: 3.906

Review 4.  Basic mechanisms and pathogenesis of venous thrombosis.

Authors:  Charles T Esmon
Journal:  Blood Rev       Date:  2009-09       Impact factor: 8.250
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.